The results of a meta-analysis of RCTs showed that curcumin provided favorable lipid profiles, and a relative advantage in liver pathologic improvement but did not reach statistical significance. 55 Moreover, many novel monotherapies target different mechanistic approaches, so “combination therapy” is an attractive approach that is currently under investigation.
← all excerpts
Pharmacological Therapeutics: Current Trends for Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD).
1
—
—